Conducted: 2-year SC studies in mouse and rat; tumours above historical controls, considered secondary to chronic inflammation
“The carcinogenic potential of volanesorsen was assessed in 2-yr repeated dose studies in mice (Study No. 304801-AS15) and rats (Study No. 304801-AS16).”
Dedicated: hERG assay, monkey ECG/BP (IV and SC), mouse Irwin CNS and respiratory studies; no relevant effects at tested doses
“There was no significant inhibition of the hERG current by ISIS 304801 at the concentrations tested (89.5 and 251 µM) and therefore an IC50 value could not be determined.”